NCT02213913 2026-03-11Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasUniversity of ChicagoPhase 1/2 Completed55 enrolled 17 charts
NCT03609593 2026-02-25Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic LeukemiaColumbia UniversityPhase 2 Completed42 enrolled
NCT04282018 2026-02-20Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and TislelizumabBeOne MedicinesPhase 1/2 Completed97 enrolled 43 charts